Sarfaraz Niazi | Adjunct Professor
University of Illinois

Sarfaraz Niazi, Adjunct Professor, University of Illinois

Professor Sarfaraz K. Niazi, Ph.D., FRSB, FPAMS, FACB, SI, Founder and CSO of Novel351k Inc., is a globally recognized pioneer of the pharmaceutical and biopharmaceutical industry, with 50+ books, 100+ research papers, 100+ patents, several approved CPs to FDA, dozens of crafted regulatory guidance, and the experience of taking many pharmaceuticals and biosimilars through regulatory approval across globe, raising hundreds of millions of dollars. He has now embarked on a global effort, in collaboration with regulatory agencies, to revolutionize the the current archaic approval process for generics and biosimilars, making it more relevant on contemporary scientific concepts—all with a goal to enhance accessibility to safer medicines. These concepts include a thermodynamic approach to compare products and a clinical approach to allow substitution without unnecessary human testing. He is an in inductee into Entrepreneur Hall of Fame, and the Forbes Magazine, Chicago Tribune and many other publications calling him “the most interesting man in the world changing healthcare.” He serves on the faculty of several major universities and is a fellow of several most prestigious learned societies. (www.niazi.com; www.pharmsci.com)

Appearances:



Festival of Biologics Day 2 @ 12:00

An AI Approach to Establish Biosimilarity—A Conceptual Paradigm Shift

last published: 31/Jan/23 09:55 GMT
last published: 31/Jan/23 09:55 GMT

back to speakers